466
Views
26
CrossRef citations to date
0
Altmetric
Inflammatory Bowel Disease

Chromogranin A as a biomarker of disease activity and biologic therapy in inflammatory bowel disease: a prospective observational study

, , , , , , & show all
Pages 942-949 | Received 22 Dec 2013, Accepted 26 Apr 2014, Published online: 04 Jun 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

R. Gacesa, A. Vich Vila, V. Collij, Z. Mujagic, A. Kurilshikov, M.D. Voskuil, E.A.M. Festen, C. Wijmenga, D.M.A.E. Jonkers, G. Dijkstra, J. Fu, A. Zhernakova, F. Imhann & R.K. Weersma. (2021) A combination of fecal calprotectin and human beta-defensin 2 facilitates diagnosis and monitoring of inflammatory bowel disease. Gut Microbes 13:1.
Read now
Maria K. Magnusson, Anders Lasson, Mats Stridsberg, Stefan Isaksson, Hans Strid & Lena Öhman. (2018) Faecal secretogranin and chromogranin levels persist over time and are unrelated to disease history and outcome in patients with ulcerative colitis. Cogent Medicine 5:1.
Read now
Ibrahim Koral Onal, Mehmet Ibis & Mehmet Arhan. (2014) Chromogranin A as a marker of disease activity in inflammatory bowel disease. Scandinavian Journal of Gastroenterology 49:12, pages 1501-1502.
Read now
Stergios Vradelis & George Kouklakis. (2014) Chromogranin A as a biomarker of disease activity and biologic therapy in inflammatory bowel disease: a prospective observational study. Scandinavian Journal of Gastroenterology 49:11, pages 1397-1397.
Read now

Articles from other publishers (22)

Georg Pongratz & Rainer H. Straub. (2023) Rolle des sympathischen Nervensystems bei chronischen EntzündungenRole of the sympathetic nervous system in chronic inflammation. Zeitschrift für Rheumatologie 82:6, pages 451-461.
Crossref
Vetri Sudar Jayaprakasam & Lisa Bodei. (2023) Neuroendocrine Tumor Therapy Response Assessment. PET Clinics 18:2, pages 267-286.
Crossref
Melina Ioannidis, Sushil K. Mahata & Geert van den Bogaart. (2022) The immunomodulatory functions of chromogranin A-derived peptide pancreastatin. Peptides 158, pages 170893.
Crossref
Elke M. Muntjewerff, Kechun Tang, Lisanne Lutter, Gustaf Christoffersson, Mara J. T. Nicolasen, Hong Gao, Gajanan D. Katkar, Soumita Das, Martin ter Beest, Wei Ying, Pradipta Ghosh, Sahar El Aidy, Bas Oldenburg, Geert van den Bogaart & Sushil K. Mahata. (2021) Chromogranin A regulates gut permeability via the antagonistic actions of its proteolytic peptides . Acta Physiologica 232:2.
Crossref
Nour Eissa, Hayam Hussein, Diane M. Tshikudi, Geoffrey N. Hendy, Charles N. Bernstein & Jean-Eric Ghia. (2020) Interdependence between Chromogranin-A, Alternatively Activated Macrophages, Tight Junction Proteins and the Epithelial Functions. A Human and In-Vivo/In-Vitro Descriptive Study. International Journal of Molecular Sciences 21:21, pages 7976.
Crossref
Yanbo Yu, Wenjing Yang, Yanqing Li & Yingzi Cong. (2020) Enteroendocrine Cells: Sensing Gut Microbiota and Regulating Inflammatory Bowel Diseases. Inflammatory Bowel Diseases 26:1, pages 11-20.
Crossref
Johanna Sundin, Mats Stridsberg, Julien Tap, Muriel Derrien, Boris Le Nevé, Joël Doré, Hans Törnblom, Magnus Simrén & Lena Öhman. (2018) Fecal chromogranins and secretogranins are linked to the fecal and mucosal intestinal bacterial composition of IBS patients and healthy subjects. Scientific Reports 8:1.
Crossref
Elke M. Muntjewerff, Gina Dunkel, Mara J. T. Nicolasen, Sushil K. Mahata & Geert van den Bogaart. (2018) Catestatin as a Target for Treatment of Inflammatory Diseases. Frontiers in Immunology 9.
Crossref
Nour Eissa, Hayam Hussein, Geoffrey N. Hendy, Charles N. Bernstein & Jean-Eric Ghia. (2018) Chromogranin-A and its derived peptides and their pharmacological effects during intestinal inflammation. Biochemical Pharmacology 152, pages 315-326.
Crossref
Ivan Kruljac, Ivan Vurnek, Sebastian Maasberg, Davor Kust, Kristina Blaslov, Blaženka Ladika Davidović, Mario Štefanović, Alma Demirović, Alen Bišćanin, Jakša Filipović-Čugura, Jasmina Marić Brozić, Ulrich-Frank Pape & Milan Vrkljan. (2018) A score derived from routine biochemical parameters increases the diagnostic accuracy of chromogranin A in detecting patients with neuroendocrine neoplasms. Endocrine 60:3, pages 395-406.
Crossref
Nour Eissa, Hayam Hussein, Laëtitia Kermarrec, Ahmed Y. Ali, Aaron Marshall, Marie-Helene Metz-Boutigue, Geoffrey N. Hendy, Charles N. Bernstein & Jean-Eric Ghia. (2017) Chromogranin-A Regulates Macrophage Function and the Apoptotic Pathway in Murine DSS colitis. Journal of Molecular Medicine 96:2, pages 183-198.
Crossref
J.J. Worthington, F. Reimann & F.M. Gribble. (2018) Enteroendocrine cells-sensory sentinels of the intestinal environment and orchestrators of mucosal immunity. Mucosal Immunology 11:1, pages 3-20.
Crossref
Nour Eissa, Hayam Hussein, Laëtitia Kermarrec, Omar Elgazzar, Marie-Helene Metz-Boutigue, Charles N. Bernstein & Jean-Eric Ghia. (2017) Chromofungin (CHR: CHGA47-66) is downregulated in persons with active ulcerative colitis and suppresses pro-inflammatory macrophage function through the inhibition of NF-κB signaling. Biochemical Pharmacology 145, pages 102-113.
Crossref
Nour Eissa, Hayam Hussein, Laëtitia Kermarrec, Jasmine Grover, Marie-Hélène Et Metz-Boutigue, Charles N. Bernstein & Jean-Eric Ghia. (2017) Chromofungin Ameliorates the Progression of Colitis by Regulating Alternatively Activated Macrophages. Frontiers in Immunology 8.
Crossref
Gautam K. Bandyopadhyay & Sushil K. Mahata. (2017) Chromogranin A Regulation of Obesity and Peripheral Insulin Sensitivity. Frontiers in Endocrinology 8.
Crossref
Magdy El-Salhy, Tefera Solomon, Trygve Hausken, Odd Helge Gilja & Jan Gunnar Hatlebakk. (2017) Gastrointestinal neuroendocrine peptides/amines in inflammatory bowel disease. World Journal of Gastroenterology 23:28, pages 5068.
Crossref
Flavio Curnis, Alice Dallatomasina, Mimma Bianco, Anna Gasparri, Angelina Sacchi, Barbara Colombo, Martina Fiocchi, Laura Perani, Massimo Venturini, Carlo Tacchetti, Suvajit Sen, Ricardo Borges, Eleonora Dondossola, Antonio Esposito, Sushil K. Mahata & Angelo Corti. (2016) Regulation of tumor growth by circulating full-length chromogranin A. Oncotarget 7:45, pages 72716-72732.
Crossref
Robin Spiller & Giles Major. (2016) IBS and IBD — separate entities or on a spectrum?. Nature Reviews Gastroenterology & Hepatology 13:10, pages 613-621.
Crossref
Sara Massironi, Alessandra Zilli, Federica Cavalcoli, Dario Conte & Maddalena Peracchi. (2016) Chromogranin A and other enteroendocrine markers in inflammatory bowel disease. Neuropeptides 58, pages 127-134.
Crossref
Gerhard Rogler & Luc Biedermann. (2015) Clinical Utility of Biomarkers in IBD. Current Gastroenterology Reports 17:7.
Crossref
Weiwei Jiang & Xuhang Li. (2015) Molecular Analysis of Inflammatory Bowel Disease: Clinically Useful Tools for Diagnosis, Response Prediction, and Monitoring of Targeted Therapy. Molecular Diagnosis & Therapy 19:3, pages 141-158.
Crossref
Masayuki Hijioka, Tetsuhide Ito, Hisato Igarashi, Nao Fujimori, Lingaku Lee, Taichi Nakamura, Robert T. Jensen & Ryoichi Takayanagi. (2014) Serum chromogranin A is a useful marker for Japanese patients with pancreatic neuroendocrine tumors. Cancer Science 105:11, pages 1464-1471.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.